The former nurse with a 30-year background that included critical care and nursing management rounded out her career as a forensic psychologist and professor before shifting gears. When she was ready to move into a new career on the heels of the COVID-19 pandemic, she knew Liquivida was the right choice. The company aligned with her belief that great health starts on the inside first and then works its way to the outside. She found that the company’s “Health is Wealth” slogan, often mentioned by the company’s founder, Sam Tejada, was not just hype. It is a core belief that influences everything the company does.
“I came across Liquivida during the pandemic, and it just seemed perfect for me,” said Ruggiero. “I was tired of forensics and traditional nursing. Aesthetics and wellness have always been a passion of mine. It only took one phone call about franchising, and I knew working with Liquivida was what I wanted to do. Their focus on cutting-edge products and services in the aesthetics space drew me in, but their attention to detail, support and focus on truly helping clients clinch the deal.”
Weight loss injections are becoming increasingly popular as a minimally invasive weight-loss option for those looking for an alternative to surgery. The FDA-approved drug Semaglutide is one of the forerunners. According to the Liquivida website:
Semaglutide is a drug that is injected under the skin in order to help regulate the hormones in the body that regulate appetite and food intake. The treatment was originally developed to help individuals with Type 2 diabetes but has recently been approved by the FDA to help with weight management for those with existing conditions related to their weight.
Semaglutide works by mimicking the specific hormone glucagon-like peptide-1 to limit appetite. The treatment is increased over a period of weeks in order to get the best results and minimize negative reactions.”
Semaglutide injections can help reduce cravings and help you feel more full, and for those with obesity-related health concerns, the FDA-approved drug has been shown to improve blood sugar and blood pressure levels. Regular use may produce results in as little as 12 weeks.
dual results may vary.
